Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs LACTOSE INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS LACTOSE INDIA DECIPHER LABS/
LACTOSE INDIA
 
P/E (TTM) x -2.1 33.2 - View Chart
P/BV x 0.6 4.3 14.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DECIPHER LABS   LACTOSE INDIA
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
LACTOSE INDIA
Mar-23
DECIPHER LABS/
LACTOSE INDIA
5-Yr Chart
Click to enlarge
High Rs6396 65.4%   
Low Rs1439 35.8%   
Sales per share (Unadj.) Rs45.152.3 86.3%  
Earnings per share (Unadj.) Rs-2.71.0 -276.5%  
Cash flow per share (Unadj.) Rs-2.24.7 -47.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs23.032.2 71.3%  
Shares outstanding (eoy) m10.1012.59 80.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.3 65.8%   
Avg P/E ratio x-14.570.6 -20.5%  
P/CF ratio (eoy) x-17.314.5 -119.2%  
Price / Book Value ratio x1.72.1 79.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m389854 45.6%   
No. of employees `000NANA-   
Total wages/salary Rs m412122 336.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m456658 69.3%  
Other income Rs m747 1,011.1%   
Total revenues Rs m529665 79.6%   
Gross profit Rs m-106115 -92.7%  
Depreciation Rs m447 9.1%   
Interest Rs m560 8.0%   
Profit before tax Rs m-4215 -283.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-153 -577.0%   
Profit after tax Rs m-2712 -221.8%  
Gross profit margin %-23.317.4 -133.9%  
Effective tax rate %35.517.5 203.4%   
Net profit margin %-5.91.8 -320.4%  
BALANCE SHEET DATA
Current assets Rs m201375 53.6%   
Current liabilities Rs m50266 18.7%   
Net working cap to sales %33.216.6 199.8%  
Current ratio x4.11.4 287.1%  
Inventory Days Days3046 66.1%  
Debtors Days Days789693 113.9%  
Net fixed assets Rs m71643 11.0%   
Share capital Rs m101126 80.2%   
"Free" reserves Rs m131280 46.9%   
Net worth Rs m232406 57.2%   
Long term debt Rs m0330 0.0%   
Total assets Rs m2721,018 26.7%  
Interest coverage x-7.61.2 -614.1%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x1.70.6 259.6%   
Return on assets %-8.17.1 -113.9%  
Return on equity %-11.63.0 -387.8%  
Return on capital %-15.810.2 -155.5%  
Exports to sales %00-   
Imports to sales %031.3 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA206 0.0%   
Fx inflow Rs m0104 0.0%   
Fx outflow Rs m0209 0.0%   
Net fx Rs m0-105 -0.0%   
CASH FLOW
From Operations Rs m-1681 -19.4%  
From Investments Rs m-43-10 420.0%  
From Financial Activity Rs m-22-84 25.7%  
Net Cashflow Rs m-80-13 595.5%  

Share Holding

Indian Promoters % 0.0 53.7 -  
Foreign collaborators % 16.4 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 83.6 46.3 180.3%  
Shareholders   34,511 16,088 214.5%  
Pledged promoter(s) holding % 0.0 26.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on COMBAT DRUGS vs LACTOSE INDIA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

COMBAT DRUGS vs LACTOSE INDIA Share Price Performance

Period COMBAT DRUGS LACTOSE INDIA S&P BSE HEALTHCARE
1-Day 0.68% -1.83% 1.18%
1-Month -17.62% -2.41% -0.75%
1-Year -1.07% 226.47% 61.82%
3-Year CAGR -24.12% 73.96% 18.16%
5-Year CAGR -10.83% 33.74% 19.79%

* Compound Annual Growth Rate

Here are more details on the COMBAT DRUGS share price and the LACTOSE INDIA share price.

Moving on to shareholding structures...

The promoters of COMBAT DRUGS hold a 16.4% stake in the company. In case of LACTOSE INDIA the stake stands at 53.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of COMBAT DRUGS and the shareholding pattern of LACTOSE INDIA.

Finally, a word on dividends...

In the most recent financial year, COMBAT DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

LACTOSE INDIA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of COMBAT DRUGS, and the dividend history of LACTOSE INDIA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.